Literature DB >> 8962158

Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor.

R Moratalla1, M Xu, S Tonegawa, A M Graybiel.   

Abstract

Stimulation of dopamine D1 receptors has profound effects on addictive behavior, movement control, and working memory. Many of these functions depend on dopaminergic systems in the striatum and D1-D2 dopamine receptor synergies have been implicated as well. We show here that deletion of the D1 dopamine receptor produces a neural phenotype in which amphetamine and cocaine, two addictive psychomotor stimulants, can no longer stimulate neurons in the striatum to express cFos or JunB or to regulate dynorphin. By contrast, haloperidol, a typical neuroleptic that acts preferentially at D2-class receptors, remains effective in inducing catalepsy and striatal Fos/Jun expression in the D1 mutants, and these behavioral and neural effects can be blocked by D2 dopamine receptor agonists. These findings demonstrate that D2 dopamine receptors can function without the enabling role of D1 receptors but that D1 dopamine receptors are essential for the control of gene expression and motor behavior by psychomotor stimulants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8962158      PMCID: PMC26239          DOI: 10.1073/pnas.93.25.14928

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments.

Authors:  A M Graybiel; R Moratalla
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs.

Authors:  J C Miller
Journal:  J Neurochem       Date:  1990-04       Impact factor: 5.372

Review 4.  Neurotransmitters and neuromodulators in the basal ganglia.

Authors:  A M Graybiel
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

5.  Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.

Authors:  P Seeman; H B Niznik; H C Guan; G Booth; C Ulpian
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum.

Authors:  A M Graybiel; R Moratalla; H A Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects.

Authors:  J R Walters; D A Bergstrom; J H Carlson; T N Chase; A R Braun
Journal:  Science       Date:  1987-05-08       Impact factor: 47.728

8.  Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.

Authors:  S P Sivam
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

9.  Sequence and expression of the rat prodynorphin gene.

Authors:  O Civelli; J Douglass; A Goldstein; E Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

10.  Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.

Authors:  X T Hu; S R Wachtel; M P Galloway; F J White
Journal:  J Neurosci       Date:  1990-07       Impact factor: 6.167

View more
  44 in total

1.  Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo.

Authors:  F Gonon
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

Review 2.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 3.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

4.  Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine.

Authors:  Amy J Ramsey; Aki Laakso; Michel Cyr; Tatyana D Sotnikova; Ali Salahpour; Ivan O Medvedev; Linda A Dykstra; Raul R Gainetdinov; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2008-01-09       Impact factor: 7.853

Review 5.  Drugs of abuse and immediate-early genes in the forebrain.

Authors:  R E Harlan; M M Garcia
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

Review 6.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

7.  c-Fos is an intracellular regulator of cocaine-induced long-term changes.

Authors:  Ming Xu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Motor-skill learning in a novel running-wheel task is dependent on D1 dopamine receptors in the striatum.

Authors:  I Willuhn; H Steiner
Journal:  Neuroscience       Date:  2008-02-06       Impact factor: 3.590

9.  Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior.

Authors:  Kyoung-Shim Kim; Ko-Woon Lee; In-Sun Baek; Chae-Moon Lim; Vaishnav Krishnan; Ja-Kyeong Lee; Eric J Nestler; Pyung-Lim Han
Journal:  J Neurochem       Date:  2008-07-31       Impact factor: 5.372

10.  Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.

Authors:  Noelia Granado; Sara Ares-Santos; Esther O'Shea; Carlos Vicario-Abejón; M Isabel Colado; Rosario Moratalla
Journal:  Neurotox Res       Date:  2009-09-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.